phase readout
saveNCT04455841: INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders
ACTIVE_NOT_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Incyte Corporation. Phase: PHASE1. Conditions: Anemia, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis
view source ↗
comments(0)
5-min edit window · permanent after that